4-benzylsulfonylpiperidine hydrochloride, 95.0%, 500mg

3-Sulfo-N-succinimidyl 4-(N-Maleimidomethyl)cyclohexane-1-carboxylate Sodium Salt100mg

1-Bromo-3-chloro-2-cyclopropylbenzene, 98%, 100mg

2-(3-(1h-Indol-5-yl)phenyl)aceticacid, 97%, 250mg

(R)-5-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride, 95%, 1g

3',5'-Dimethyl-2,2,2-trifluoroacetophenone, 97.0%, 1g

4'-bromo-3-(3-bromophenyl)-2'-fluoropropiophenone, 97.0%, 1g

tert-Butyl ethynyl(phenyl)carbamate, 98%, 100mg

3,6-Dibromopyridazine, 98.0%, 100g

Ethyl 2-(((3aR,4S,6R,6aS)-6-(((benzyloxy)carbonyl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate, 98%, 100mg

2-(2-Chloro-4-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

Closing caps LABOCAP for 21/23 mm, silver 100 pcs

Sodium hydroxide, min. 97%, pa, ACS, in pellets, 5 kg, plastic packaging.